Orthovita, Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Orthovita, Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Orthovita, Inc.. The Group's principal activity is to develop, manufacture and market synthetic bone substitutes for orthopaedic applications that are useful in spine and joint replacements. The Group develops and markets synthetic-based biomaterial products for use in spine surgery, the repair of osteoporotic fractures, and a range of clinical needs in the trauma, joint reconstruction, revision and extremities markets. The products are based on two platforms: The products include VITOSS Bone Graft Substitute technology platforms, which are designed to address the non-structural, bone-graft market and VITAGEL Surgical Hemostat, which is a matrix for soft-tissue healing.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report